Related references
Note: Only part of the references are listed.Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine
A. Rahmann et al.
CEPHALALGIA (2008)
Pituitary adenylate cyclase-activating polypeptide induces pial arteriolar vasodilation through cyclooxygenase-dependent and independent mechanisms in newborn pigs
Laura Lenti et al.
BRAIN RESEARCH (2007)
Effect of two novel CGRP-binding compounds in a closed cranial window rat model
Louise Juhl et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
The effect of intravenous PACAP38 on cerebral hemodynamics in healthy volunteers
Steffen Birk et al.
REGULATORY PEPTIDES (2007)
A systematic comparison of intracellular cyclic AMP and calcium signalling highlights complexities in VPAC/PAC receptor pharmacology
Louise Dickson et al.
NEUROPHARMACOLOGY (2006)
Vasoactive intestinal polypeptide evokes only a minimal headache in healthy volunteers
J. M. Hansen et al.
CEPHALALGIA (2006)
Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells:: Consequences for signaling by VIP and PACAP
EM Lutz et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2006)
PACAP - A multifacetted neuropeptide
J Fahrenkrug
CHRONOBIOLOGY INTERNATIONAL (2006)
Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients
JL Bellamy et al.
HEADACHE (2006)
VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes
L Åkesson et al.
ENDOCRINOLOGY (2005)
Effect of hypotension and carbon dioxide changes in an improved genuine closed cranial window rat model
KA Petersen et al.
CEPHALALGIA (2005)
Pituitary adenylate cyclase activating polypeptide: A potential neuroprotective peptide
A Somogyvari-Vigh et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the rat
KA Petersen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Origin of PACAP-immunoreactive nerve fibers innervating the subarachnoidal blood vessels of the rat brain
F Martin et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2004)
Molecular pharmacology and structure of VPAC receptors for VIP and PACAP
M Laburthe et al.
REGULATORY PEPTIDES (2002)
Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia
M Knutsson et al.
NEUROREPORT (2002)
Neuronal messengers in the human cerebral circulation
S Gulbenkian et al.
PEPTIDES (2001)
Maxadilan specifically interacts with PAC1 receptor, which is a dominant form of PACAP/VIP family receptors in cultured rat cortical neurons
I Tatsuno et al.
BRAIN RESEARCH (2001)
Immunohistochemical localization of the VIP1 receptor (VPAC1R) in rat cerebral blood vessels:: Relation to PACAP and VIP containing nerves
J Fahrenkrug et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2000)